Vericel Corporation (VCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VCEL | STOK | CLDX | ||
| Company | Vericel Corporation | Stoke Therapeutics Inc | Celldex Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 36.95 | 33.13 | 27.90 | ||
| High | 36.95 | 35.43 | 27.90 | ||
| Low | 36.32 | 32.47 | 26.82 | ||
| Latest | 36.49 | 32.98 | 27.09 | ||
| Change | -0.05 | +0.59 | -0.42 | ||
| % Change | -0.14% | +1.82% | -1.53% | ||
| Volume | 463,600 | 934,600 | 864,300 | ||
| 20-Day Average Volume | 599,370 | 978,170 | 781,260 | ||
| Previous Close | 36.54 | 32.39 | 27.51 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 38.38 | 30.64 | 27.11 | ||
| 20-Day Raw Stochastic | 9.38% | 75.79% | 42.88% | ||
| 20-Day Relative Strength | 47.02 | 58.51 | 52.18 | ||
| Weighted Alpha | -31.66 | +213.35 | +14.99 | ||
| Today's Opinion | 32% Sell | 100% Buy | 88% Buy | ||
| Previous Opinion | 32% Sell | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 8% Buy | 56% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.17% since 12/08/25 | -0.06% since 12/08/25 | -9.09% since 12/08/25 | ||
| Low | 36.32 on 12/15/25 | 30.17 on 12/10/25 | 26.82 on 12/15/25 | ||
| High | 38.70 on 12/10/25 | 35.43 on 12/15/25 | 29.91 on 12/09/25 | ||
| 1-Month | |||||
| %Chg | -8.45% since 11/14/25 | +24.41% since 11/14/25 | +6.03% since 11/14/25 | ||
| Low | 35.85 on 12/05/25 | 25.31 on 11/17/25 | 24.53 on 11/19/25 | ||
| High | 42.67 on 11/26/25 | 35.43 on 12/15/25 | 30.50 on 12/08/25 | ||
| 3-Month | |||||
| %Chg | +16.14% since 09/15/25 | +40.94% since 09/15/25 | +10.57% since 09/15/25 | ||
| Low | 29.24 on 09/25/25 | 20.32 on 11/05/25 | 22.10 on 11/11/25 | ||
| High | 43.00 on 11/06/25 | 38.69 on 10/16/25 | 30.50 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | -14.48% since 06/13/25 | +186.04% since 06/13/25 | +27.42% since 06/13/25 | ||
| Low | 29.24 on 09/25/25 | 11.17 on 06/25/25 | 19.52 on 06/30/25 | ||
| High | 43.57 on 06/30/25 | 38.69 on 10/16/25 | 30.50 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,847,974 | 1,850,020 | 1,828,012 | ||
| Shares Outstanding, K | 50,574 | 57,117 | 66,449 | ||
| Annual Sales | 237,220,000 | 36,560,000 | 7,020,000 | ||
| Annual Net Income | 10,360,000 | -88,980,000 | -157,860,000 | ||
| Last Quarter Sales | 67,500,000 | 10,630,000 | 730,000 | ||
| Last Quarter Net Income | 5,070,000 | -38,350,000 | -56,600,000 | ||
| 60-Month Beta | 1.20 | 1.14 | 1.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.10 on 11/06/25 | -0.65 on 11/04/25 | -1.01 on 11/10/25 | ||
| Latest Earnings Date | 02/26/26 | 03/17/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 155.79 | 49.39 | 0.00 | ||